+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Intelligence in Genomics Market by Application, AI Technique, Service, Sequencing Type, End User - Global Forecast to 2030- Product Image
Artificial Intelligence in Genomics Market by Application, AI Technique, Service, Sequencing Type, End User - Global Forecast to 2030- Product Image
Sale

Artificial Intelligence in Genomics Market by Application, AI Technique, Service, Sequencing Type, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5612960
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Artificial Intelligence in Genomics Market grew from USD 740.23 million in 2024 to USD 984.96 million in 2025. It is expected to continue growing at a CAGR of 32.80%, reaching USD 4.06 billion by 2030.

Pioneering the Convergence of AI and Genomics

Genomic research is undergoing a profound evolution as advances in artificial intelligence deliver unprecedented capabilities for decoding complex biological data. The convergence of high-throughput sequencing, cloud-native computing, and sophisticated algorithms is transforming our understanding of genetic architecture, disease mechanisms, and crop improvement at a scale and speed that were unthinkable just a decade ago. This executive summary offers an authoritative guide to the pivotal developments, strategic inflection points, and regional dynamics shaping the AI-powered genomics ecosystem.

With rising investments in bioinformatics platforms and multidisciplinary collaborations between biologists, data scientists, and clinicians, the industry is poised to deliver breakthroughs in personalized medicine, agricultural resilience, and drug discovery. Yet as the landscape accelerates, stakeholders must navigate shifting regulatory frameworks, supply chain challenges, and evolving competitive pressures. This introduction frames the key themes that follow, setting the stage for a comprehensive analysis aimed at decision-makers who demand clarity, depth, and actionable insights.

Unprecedented Transformational Shifts Reshaping Genomic Research

The genomics landscape is being redefined by transformative shifts in computational power and algorithmic sophistication. Deep learning architectures are now capable of identifying subtle patterns in genomic variation that elude traditional statistical methods, enabling breakthroughs in target validation and biomarker discovery. Concurrently, natural language processing tools are streamlining the extraction of meaningful insights from vast repositories of scientific literature, expediting hypothesis generation and experimental design.

Machine learning models are driving precision agriculture by optimizing crop improvement pipelines and enhancing livestock breeding strategies, while companion diagnostics powered by AI are delivering more accurate patient stratification in clinical trials. Meanwhile, cloud-enabled analytics environments are collapsing timelines for preclinical testing and accelerating time-to-value for novel therapeutics. As these capabilities mature, the balance of power is shifting toward organizations that integrate AI across the entire genomic life cycle-from data ingestion and sequencing through interpretation and clinical application. This transition is both profound and irreversible, marking a new era in which data-driven insights underpin every strategic decision.

Evaluating the 2025 US Tariff Policy on Genomic AI Innovations

In 2025, the implementation of new United States tariffs on imported sequencing reagents, instrumentation, and high-performance computing hardware introduced significant headwinds for genomic AI ventures. By increasing the cost basis for key inputs, these measures have driven companies to reevaluate sourcing strategies and localize critical components of their supply chain. As a result, domestic manufacturing partnerships and consortium-based procurement models have emerged as viable countermeasures to stabilize operational expenses.

Furthermore, tariff-induced price adjustments have incentivized collaborative agreements with academic institutions and contract research organizations to share infrastructure investments and maintain competitive pricing for end-users. Despite these challenges, many market participants have leveraged the elevated cost environment to justify strategic alliances that enhance resilience and foster technology transfer. In parallel, selective exemptions for sequencing services and bioinformatics software have created pockets of opportunity, underscoring the need for granular analysis when assessing regional and vertical market dynamics.

Comprehensive Insights from Segmentation Analysis

A segmentation lens reveals how diverse applications are converging to expand the boundaries of AI-driven genomics. Within agriculture and animal genomics, advancements in crop improvement and livestock breeding underscore the role of machine learning in optimizing phenotypic selection and genetic diversity. In diagnostics, clinical and research workflows are now powered by AI-enhanced pattern recognition that accelerates disease detection and stratifies patient cohorts with higher precision. Drug discovery segments encompassing lead identification, preclinical testing, and target validation are benefiting from predictive models that reduce experimental bottlenecks and refine candidate selection. Precision medicine is advancing through companion diagnostics and personalized therapeutics supported by pharmacogenomics algorithms that tailor interventions to individual genetic profiles.

When the market is viewed through the prism of AI technique, deep learning frameworks such as autoencoders, convolutional neural networks, and recurrent neural networks are at the forefront of sequence annotation and variant calling. Machine learning approaches, including reinforcement, supervised, and unsupervised learning, are facilitating pattern discovery in multiomic datasets. Natural language processing applications like sentiment analysis and text mining are extracting actionable intelligence from clinical notes and research publications.

A service-oriented perspective highlights bioinformatics offerings for annotation, data analysis, and interpretation, while consulting practices provide implementation support and strategy development. Sequencing services from exome to transcriptome and whole genome applications coexist alongside software and platform solutions delivered via cloud-based and on-premise architectures. Sequencing type differentiation between next generation platforms-Illumina, Ion Torrent, PacBio-and traditional Sanger methods like capillary and fluorescence continues to inform technology selection. Finally, end users across academic and research institutes, diagnostic laboratories in hospitals and clinics, and biopharmaceutical companies from biotech firms to large pharma each leverage AI-genomics capabilities to meet unique objectives.

Regional Dynamics Driving Genomic AI Adoption

Regional dynamics are playing a decisive role in determining the pace and direction of AI integration within genomics. In the Americas, robust R&D funding, established regulatory pathways, and high-capacity sequencing centers are fueling large-scale projects in precision medicine and agricultural genomics. Public-private partnerships in North America are driving in-house AI platforms, while collaborative networks in Latin America are tailoring genome editing and breeding solutions for local crops.

Across Europe, the Middle East and Africa, the European Union’s stringent data privacy and medical device regulations coexist with innovation funding schemes, incentivizing pan-regional consortia that blend university research with commercial development. In the Middle East, nascent genomics programs are attracting global talent, and in Africa, public health initiatives are leveraging AI-driven diagnostics to address endemic diseases.

The Asia-Pacific region is characterized by government-led genomics roadmaps in China and Japan, which are accelerating next generation sequencing infrastructure and AI-backed biopharma pipelines. Australia’s precision medicine strategy emphasizes partnerships between hospitals and AI startups, while India’s cost-competitive bioinformatics services create a fertile ground for scalable, cloud-based genomic analysis solutions.

Spotlight on Leading Innovators and Collaborators

Leading sequencing platform providers are embedding AI modules within their instruments to deliver real-time base calling, variant detection, and quality control, thereby reducing manual intervention and accelerating throughput. Technology conglomerates are offering end-to-end cloud platforms that integrate data capture, storage, and analytics, enabling seamless collaboration across distributed research teams. In parallel, genomic startups are differentiating through specialized AI algorithms for rare variant discovery and epigenomic profiling, often forging licensing agreements with larger players to expand their market reach.

Strategic alliances between biopharma companies and AI vendors are co-developing biomarker panels that support targeted oncology trials and immunotherapy stratification. Academic centers are partnering with machine learning research labs to validate novel computational approaches, translating proof-of-principle studies into commercial applications. Meanwhile, software providers focused on user-friendly graphical interfaces are lowering the barrier to entry for biologists, democratizing access to advanced analytics without requiring specialized coding expertise. Together, these diverse actors are creating an ecosystem in which innovation is driven by both technological prowess and collaborative execution.

Strategic Imperatives for Industry Leaders to Excel

Industry leaders should prioritize robust data governance frameworks that ensure the integrity, security, and interoperability of genomic datasets. Investment in hybrid cloud architectures will offer the flexibility needed to handle surges in sequencing output while maintaining compliance with regional data protection mandates. Cross-disciplinary teams composed of geneticists, data engineers, and regulatory experts are essential to bridge the divide between computational models and laboratory practice.

Leaders should cultivate strategic partnerships with academic institutions and contract research organizations to share infrastructure, validate novel algorithms, and accelerate time-to-insight. Pilot projects that target high-impact use cases-such as real-time diagnostic decision support or rapid crop genotype screening-can demonstrate ROI and build internal advocacy for broader AI deployments. Continuous upskilling initiatives, including hands-on workshops and collaborative hackathons, will empower scientists to leverage emerging tools effectively. Finally, proactive engagement with regulatory bodies will shape frameworks that balance innovation with patient safety and public trust.

Rigorous Methodology Underpinning the Analysis

This analysis is underpinned by a rigorous research methodology that combines primary and secondary sources to deliver a comprehensive view of the AI-genomics marketplace. Primary insights were gathered through in-depth interviews with leading researchers, C-level executives, and regulatory experts, providing nuanced perspectives on technology adoption and strategic priorities. Secondary research leveraged peer-reviewed journals, conference proceedings, patent filings, and company reports to map technological trajectories and competitive positioning.

Quantitative data points were cross-validated against global regulatory databases and public funding disclosures to ensure accuracy and relevance. Segmentation frameworks for application, AI technique, service, sequencing type, and end user were applied to structure the market analysis, while regional evaluation incorporated country-level policies and infrastructure assessments. Case studies highlighting successful deployments of AI-driven genomic solutions were selected to illustrate best practices and operational challenges.

Shaping the Future of Genomic Research with AI

As artificial intelligence continues to permeate every facet of genomic research, stakeholders across academia, industry, and government must embrace a collaborative, data-driven approach to innovation. The intersection of AI and genomics not only promises more precise therapeutics and resilient crops but also heralds a new paradigm in which biological complexity is illuminated by predictive analytics.

By understanding the transformative shifts, tariff-related implications, segmentation nuances, regional dynamics, and competitive landscapes outlined herein, decision-makers will be equipped to chart a strategic course that balances risk with opportunity. The future of medicine and agriculture hinges on our collective ability to harness AI’s potential, and the insights presented in this executive summary offer a clear roadmap for doing so.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Agriculture & Animal Genomics
      • Crop Improvement
      • Livestock Breeding
    • Diagnostics
      • Clinical Diagnostics
      • Research Diagnostics
    • Drug Discovery
      • Lead Identification
      • Preclinical Testing
      • Target Validation
    • Precision Medicine
      • Companion Diagnostics
      • Personalized Therapeutics
      • Pharmacogenomics
  • AI Technique
    • Deep Learning
      • Autoencoders
      • Convolutional Neural Networks
      • Recurrent Neural Networks
    • Machine Learning
      • Reinforcement Learning
      • Supervised Learning
      • Unsupervised Learning
    • Natural Language Processing
      • Sentiment Analysis
      • Text Mining
  • Service
    • Bioinformatics Services
      • Annotation
      • Data Analysis
      • Interpretation
    • Consulting
      • Implementation Support
      • Strategy Development
    • Sequencing Services
      • Exome Sequencing
      • Transcriptome Sequencing
      • Whole Genome Sequencing
    • Software & Platform
      • Cloud-Based
      • On-Premise
  • Sequencing Type
    • Next Generation Sequencing
      • Illumina
      • Ion Torrent
      • PacBio
    • Sanger Sequencing
      • Capillary
      • Fluorescence
  • End User
    • Academic & Research
      • Research Institutes
      • Universities
    • Hospitals & Clinics
      • Diagnostic Laboratories
      • Medical Centers
    • Pharma & Biotech
      • Biotech Firms
      • Large Pharma
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • QIAGEN N.V.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • BGI Genomics Co., Ltd
  • NanoString Technologies, Inc.
  • SOPHiA Genetics SA

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Artificial Intelligence in Genomics Market, by Application
8.1. Introduction
8.2. Agriculture & Animal Genomics
8.2.1. Crop Improvement
8.2.2. Livestock Breeding
8.3. Diagnostics
8.3.1. Clinical Diagnostics
8.3.2. Research Diagnostics
8.4. Drug Discovery
8.4.1. Lead Identification
8.4.2. Preclinical Testing
8.4.3. Target Validation
8.5. Precision Medicine
8.5.1. Companion Diagnostics
8.5.2. Personalized Therapeutics
8.5.3. Pharmacogenomics
9. Artificial Intelligence in Genomics Market, by AI Technique
9.1. Introduction
9.2. Deep Learning
9.2.1. Autoencoders
9.2.2. Convolutional Neural Networks
9.2.3. Recurrent Neural Networks
9.3. Machine Learning
9.3.1. Reinforcement Learning
9.3.2. Supervised Learning
9.3.3. Unsupervised Learning
9.4. Natural Language Processing
9.4.1. Sentiment Analysis
9.4.2. Text Mining
10. Artificial Intelligence in Genomics Market, by Service
10.1. Introduction
10.2. Bioinformatics Services
10.2.1. Annotation
10.2.2. Data Analysis
10.2.3. Interpretation
10.3. Consulting
10.3.1. Implementation Support
10.3.2. Strategy Development
10.4. Sequencing Services
10.4.1. Exome Sequencing
10.4.2. Transcriptome Sequencing
10.4.3. Whole Genome Sequencing
10.5. Software & Platform
10.5.1. Cloud-Based
10.5.2. On-Premise
11. Artificial Intelligence in Genomics Market, by Sequencing Type
11.1. Introduction
11.2. Next Generation Sequencing
11.2.1. Illumina
11.2.2. Ion Torrent
11.2.3. PacBio
11.3. Sanger Sequencing
11.3.1. Capillary
11.3.2. Fluorescence
12. Artificial Intelligence in Genomics Market, by End User
12.1. Introduction
12.2. Academic & Research
12.2.1. Research Institutes
12.2.2. Universities
12.3. Hospitals & Clinics
12.3.1. Diagnostic Laboratories
12.3.2. Medical Centers
12.4. Pharma & Biotech
12.4.1. Biotech Firms
12.4.2. Large Pharma
13. Americas Artificial Intelligence in Genomics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Artificial Intelligence in Genomics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Artificial Intelligence in Genomics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd
16.3.2. Thermo Fisher Scientific Inc.
16.3.3. Illumina, Inc.
16.3.4. Agilent Technologies, Inc.
16.3.5. QIAGEN N.V.
16.3.6. Bio-Rad Laboratories, Inc.
16.3.7. PerkinElmer, Inc.
16.3.8. BGI Genomics Co., Ltd
16.3.9. NanoString Technologies, Inc.
16.3.10. SOPHiA Genetics SA
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET MULTI-CURRENCY
FIGURE 2. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET MULTI-LANGUAGE
FIGURE 3. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AI TECHNIQUE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AI TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SERVICE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SERVICE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SEQUENCING TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SEQUENCING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CROP IMPROVEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY LIVESTOCK BREEDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY RESEARCH DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY LEAD IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PRECLINICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PRECISION MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PERSONALIZED THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PRECISION MEDICINE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AI TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AUTOENCODERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY RECURRENT NEURAL NETWORKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DEEP LEARNING, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY REINFORCEMENT LEARNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SUPERVISED LEARNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY UNSUPERVISED LEARNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SENTIMENT ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY TEXT MINING, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY ANNOTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY INTERPRETATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CONSULTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY IMPLEMENTATION SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY STRATEGY DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SEQUENCING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SEQUENCING SERVICES, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SOFTWARE & PLATFORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SOFTWARE & PLATFORM, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SEQUENCING TYPE, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY ILLUMINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY ION TORRENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PACBIO, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CAPILLARY, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SANGER SEQUENCING, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY MEDICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PHARMA & BIOTECH, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY BIOTECH FIRMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PRECISION MEDICINE, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AI TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DEEP LEARNING, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SEQUENCING SERVICES, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SOFTWARE & PLATFORM, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SEQUENCING TYPE, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SANGER SEQUENCING, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PRECISION MEDICINE, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AI TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DEEP LEARNING, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SEQUENCING SERVICES, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SOFTWARE & PLATFORM, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SEQUENCING TYPE, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SANGER SEQUENCING, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 126. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 128. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 129. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 130. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PRECISION MEDICINE, 2018-2030 (USD MILLION)
TABLE 131. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AI TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 132. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DEEP LEARNING, 2018-2030 (USD MILLION)
TABLE 133. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 134. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
TABLE 135. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 136. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 137. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 138. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SEQUENCING SERVICES, 2018-2030 (USD MILLION)
TABLE 139. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SOFTWARE & PLATFORM, 2018-2030 (USD MILLION)
TABLE 140. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SEQUENCING TYPE, 2018-2030 (USD MILLION)
TABLE 141. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 142. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SANGER SEQUENCING, 2018-2030 (USD MILLION)
TABLE 143. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH, 2018-2030 (USD MILLION)
TABLE 145. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 146. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 147. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 149. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 150. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 151. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PRECISION MEDICINE, 2018-2030 (USD MILLION)
TABLE 152. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AI TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 153. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DEEP LEARNING, 2018-2030 (USD MILLION)
TABLE 154. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 155. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
TABLE 156. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 157. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 158. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 159. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SEQUENCING SERVICES, 2018-2030 (USD MILLION)
TABLE 160. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SOFTWARE & PLATFORM, 2018-2030 (USD MILLION)
TABLE 161. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SEQUENCING TYPE, 2018-2030 (USD MILLION)
TABLE 162. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 163. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SANGER SEQUENCING, 2018-2030 (USD MILLION)
TABLE 164. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH, 2018-2030 (USD MILLION)
TABLE 166. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 167. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PRECISION MEDICINE, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AI TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DEEP LEARNING, 2018-2030 (USD MILLION)
TABLE 175. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 176. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
TABLE 177. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 178. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 179. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 180. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SEQUENCING SERVICES, 2018-2030 (USD MILLION)
TABLE 181. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SOFTWARE & PLATFORM, 2018-2030 (USD MILLION)
TABLE 182. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SEQUENCING TYPE, 2018-2030 (USD MILLION)
TABLE 183. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 184. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SANGER SEQUENCING, 2018-2030 (USD MILLION)
TABLE 185. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH, 2018-2030 (USD MILLION)
TABLE 187. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 188. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 189. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 191. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 192. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 193. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PRECISION MEDICINE, 2018-2030 (USD MILLION)
TABLE 194. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AI TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 195. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DEEP LEARNING, 2018-2030 (USD MILLION)
TABLE 196. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 197. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
TABLE 198. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 199. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 200. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 201. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SEQUENCING SERVICES, 2018-2030 (USD MILLION)
TABLE 202. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SOFTWARE & PLATFORM, 2018-2030 (USD MILLION)
TABLE 203. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SEQUENCING TYPE, 2018-2030 (USD MILLION)
TABLE 204. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 205. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SANGER SEQUENCING, 2018-2030 (USD MILLION)
TABLE 206. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH, 2018-2030 (USD MILLION)
TABLE 208. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 209. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PRECISION MEDICINE, 2018-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AI TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DEEP LEARNING, 2018-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SEQUENCING SERVICES, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SOFTWARE & PLATFORM, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SEQUENCING TYPE, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SANGER SEQUENCING, 2018-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH, 2018-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PRECISION MEDICINE, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AI TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DEEP LEARNING, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 240. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 242. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 244. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SEQUENCING SERVICES, 2018-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SOFTWARE & PLATFORM, 2018-2030 (USD MILLION)
TABLE 246. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SEQUENCING TYPE, 2018-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 248. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SANGER SEQUENCING, 2018-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH, 2018-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 252. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 253. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 255. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 256. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 257. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PRECISION MEDICINE, 2018-2030 (USD MILLION)
TABLE 258. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AI TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 259. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DEEP LEARNING, 2018-2030 (USD MILLION)
TABLE 260. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 261. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
TABLE 262. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 263. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 264. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 265. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SEQUENCING SERVICES, 2018-2030 (USD MILLION)
TABLE 266. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SOFTWARE & PLATFORM, 2018-2030 (USD MILLION)
TABLE 267. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SEQUENCING TYPE, 2018-2030 (USD MILLION)
TABLE 268. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 269. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SANGER SEQUENCING, 2018-2030 (USD MILLION)
TABLE 270. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH, 2018-2030 (USD MILLION)
TABLE 272. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 273. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 274. FRANCE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. FRANCE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 276. FRANCE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 277. FRANCE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 278. FRANCE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PRECISION MEDICINE, 2018-2030 (USD MILLION)
TABLE 279. FRANCE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AI TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 280. FRANCE ARTIFICIAL INTELLIGENCE IN GEN

Companies Mentioned

The companies profiled in this Artificial Intelligence in Genomics market report include:
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • QIAGEN N.V.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • BGI Genomics Co., Ltd
  • NanoString Technologies, Inc.
  • SOPHiA Genetics SA

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 984.96 Million
Forecasted Market Value ( USD ) by 2030 $ 4060 Million
Compound Annual Growth Rate32.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Artificial Intelligence (AI) in Genomics Market - Focused Insights 2024-2029 - Product Image

Artificial Intelligence (AI) in Genomics Market - Focused Insights 2024-2029

  • Report
  • 159 Pages
  • Global
From
AI in Genomics Market Outlook Report: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2034 - Product Image

AI in Genomics Market Outlook Report: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2034

  • Report
  • 150 Pages
  • Global
From
Artificial Intelligence (AI) in Genomics Market - Forecasts from 2024 to 2029 - Product Image

Artificial Intelligence (AI) in Genomics Market - Forecasts from 2024 to 2029

  • Report
  • 140 Pages
  • Global
From
AI In Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

AI In Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 185 Pages
  • Global
From
AI in Genomics Market Outlook to 2028 - Product Image

AI in Genomics Market Outlook to 2028

  • Report
  • 89 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.